Pfizer's Q1 revenues jump on Wyeth effect
This article was originally published in Scrip
Executive Summary
Pfizer has reported a huge jump in its first-quarter revenue, owing to the acquisition of Wyeth which was completed last October, but expenses from the deal dampened net income.